Ambasilide

This classification denotes an antiarrhythmic agent with the molecular formula C21H25N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 012LYD6KXM, chemically known as 3-(p-aminobenzoyl)-7-benzyl-3,7-diazabicyclo(3.3.1)nonane but more generally known as ambasilide, which bears US NIH Compound Identifier 71270. European Medicines Agency schedules Ambasilide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05393MIG. The term AMBASILIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 3, No. 3, 1989, List 29). AMBASILIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule ambasilide under HS 29333999 and SITC 51574. As of Q4 2014, AMBASILIDE remains US FDA's Preferred Term for this commodity. Ambasilide bears US NLM identifiers UMLS ID C0169222 and NCI Concept Code C72573. SMILES: O=C(N1CC2CC(CN(C2)CC2CCCCC2)C1)C1CCC(N)CC1.